United Therapeutics Corp (NASDAQ:UTHR)

129.47
Data as of Nov 21
 +0.25 / +0.19%
Today’s Change
84.63
Today|||52-Week Range
136.93
+14.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$6.2B

Company Description

United Therapeutics Corp. operates as a biotechnology company, which focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer. The company operates in two business segments: Pharmaceuticals and Telemedicine. Its primary product Remodulin is used for the treatment of pulmonary arterial hypertension and the company also develops glycol-biological antiviral agents for the treatment of infectious diseases, such as Hepatitis C. United Therapeutics was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Contact Information

United Therapeutics Corp.
1040 Spring Street
Silver Spring Maryland 20910
P:(301) 608-9292
Investor Relations:
(202) 483-7000

Employees

Shareholders

Other institutional61.62%
Mutual fund holders51.96%
Individual stakeholders12.63%

Top Executives

Martine A. RothblattChairman & Chief Executive Officer
Roger A. JeffsPresident, Chief Operating Officer & Director
John Maxim FerrariChief Financial Officer & Treasurer
Shola OyewoleChief Information Officer
Paul A. MahonSecretary, Executive VP & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.